Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

PhotoCure reports preliminary results from phase III trial of Metvix in basal cell carcinoma

Nov. 20, 2001

Investigational cancer drug GS-7836 moves to phase I testing

Nov. 20, 2001

Supratek initiates enrollment for SP-1049C phase II trial

Nov. 20, 2001

FR-900482 analogues with antitumor activity under study in Japan

Nov. 19, 2001

Merck receives patent coverage for new GnRH antagonists

Nov. 19, 2001

New antitumor/antibacterial compounds isolated from Penicillium sp. in Japan

Nov. 16, 2001

Improved taxane anticancer agents discovered during research at BMS

Nov. 16, 2001

Onco TCS pilot phase II trials expanded to include combination therapy with etoposide

Nov. 15, 2001

Active Biotech cleared to begin phase II trials of TTS in renal cell cancer

Nov. 15, 2001

Pharma Mar identifies novel antitumor compounds from marine sponge

Nov. 14, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 4, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...